C-type lectin domain family 4 member C

BE0010522ProteinHumansCLEC4C

Lectin-type cell surface receptor which may play a role in antigen capturing by dendritic cells (PubMed:11748283, PubMed:21880719, PubMed:25995448). It is acted on by 2 drugs in DrugBank.

Gene name
CLEC4C
UniProtKB entry
Q8WTT0Swiss-Prot
Cellular location
Cell membrane
Residues / weight
213 residues · 25,037 Da
Also known as
BDCA-2 · BDCA2 · Blood dendritic cell antigen 2 · C-type lectin superfamily member 7 · CLECSF11

Resolves to

Protein
UniProtQ8WTT0UniProt nameCLC4C_HUMAN
Gene
HGNCHGNC:13258NCBI Gene170482GeneCardsCLEC4C
Pharmacology
KEGGhsa:170482
Structure
PDB3WBPPDB3WBQPDB3WBR
Drugs

What you can answer from here — as of October 31, 2023

2DrugsApproved to experimental, with action, bond type and pharmacological action
Sign in
1Clinical trialTrials of drugs acting on it, by phase and status
Sign in
1GO termFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on C-type lectin domain family 4 member C, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In